Featured News
AIM Blog
Recognizing AIM’s January Advocate of the Month: Ben Woodworth
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted by Alzheimer’s and all other dementia remain top-of-mind in Congres...
All News
Press Release
Congress Takes Action on Critical Alzheimer’s Legislation to Ensure Addressing Alzheimer’s Remains a National Priority and Continue Momentum on Research Funding
Washington, D.C., May 16, 2022 — Today, the Alzheimer's Association and the Alzheimer's Impact Movement (AIM) are proud to support...
AIM Blog
Pathway to Treatments Through Accelerated Approvals
This week, the Alzheimer's Association sponsored, and the Hill hosted, a discussion on accelerated approval with policymakers, experts and patient...
AIM Blog
Securing Critical Funding for Alzheimer’s and Other Dementia Research
Earlier this month, a $289 million increase in funding for Alzheimer's and other dementia research at the National Institutes of...
Press Release
Congress Agrees on $289 Million Alzheimer’s Research Funding Increase and Robust Investment in Alzheimer’s Public Health Infrastructure
Washington, D.C., March 9, 2022 — Congressional leaders have announced a $289 million increase for Alzheimer's and dementia research funding...
AIM Blog
Thank You Advocates for Advancing Our Mission
Over the last couple of weeks, AIM advocates across the country met with over 350 congressional offices to share their...
AIM Blog
For Individuals with Early-Stage Alzheimer’s Disease: A Decision With Devastating Repercussions
For people living with mild cognitive impairment (MCI) due to Alzheimer's disease, the Centers for Medicare & Medicaid Services (CMS)...